A Single-Arm, Virtual Clinical Trial to Evaluate the Effects of a Sleep Supporting Beverage and Two Coffee Substitute Products
NCT ID: NCT06146517
Last Updated: 2024-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2023-08-31
2024-01-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of the Efficacy and Safety of CHI-921 in Insomnia.
NCT03984604
A Crossover Trial to Examine the Efficacy of a Powder to Improve Sleep Quality and Performance
NCT07183735
A Randomized, Placebo-Controlled, Double-Blind, Crossover Study to Evaluate the Effects of Three Doses of the Dietary Supplement oréVida™ on Alertness, Attention and Concentration in Healthy Men and Women
NCT01143194
An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients with Severe Insomnia
NCT06053840
Appraising Clinical Trial Experiences of Patients With Insomnia
NCT05978271
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Clevr Blends Arm
Weeks 1-4: Participants will take one 6 oz serving daily of Clevr Blends Sleeptime 20 - 60 minutes before bed. The product comes with a scoop that measures 3 tsp. Participants should mix a full scoop with 6oz of water and froth using the frother that will be provided.
Weeks 5-8: Participants will take one serving daily of Clevr Blends Matcha, before 1pm. The product comes with a scoop that measures 3 tsp. Participants should mix a full scoop with 6oz of water and froth using the frother that will be provided.
Weeks 9-12: Participants will take one serving daily of Clevr Blends Chai, before 1pm. The product comes with a scoop that measures 3 tsp. Participants should mix a full scoop with 6oz of water and froth using the frother that will be provided.
Clevr Sleeptime
Participants will trial Clevr Blends Sleeptime during weeks 1-4.
Clevr Matcha
Participants will trial Clevr Matcha during weeks 5-8.
Clevr Chai
Participants will trial Clevr Chai during weeks 9-12.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clevr Sleeptime
Participants will trial Clevr Blends Sleeptime during weeks 1-4.
Clevr Matcha
Participants will trial Clevr Matcha during weeks 5-8.
Clevr Chai
Participants will trial Clevr Chai during weeks 9-12.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 28-42.
* Generally healthy without any uncontrolled or chronic disease.
* Must consume a beverage containing low to moderate amount of caffeine once daily, defined as consuming the caffeine equivalent of less than or equal to one cup of coffee daily.
* Looking for healthier alternatives to caffeine.
* Currently owns a wearable sleep tracking device (e.g. Fitbit, Whoop, Oura etc) and has been wearing consistently for 4 weeks.
* Resident of the USA.
Exclusion Criteria
* Anyone with a formal diagnosis of insomnia.
* Any pre-existing or chronic conditions that would prevent participants from adhering to the protocol.
* Women that are pregnant, breastfeeding or attempting to conceive during the duration of the trial.
* Unwilling to follow the protocol.
* Participants that consume more than two caffeinated drinks daily.
* Participants that have little to no caffeine daily, equivalent to less than 1 cup of coffee daily.
* Is not a resident of the USA.
28 Years
42 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Citruslabs
INDUSTRY
Clevr Blends
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Citruslabs
Santa Monica, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20341
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.